Journal of Neuroimmunology

Papers
(The median citation count of Journal of Neuroimmunology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Editorial Board107
MicroRNAs are dysregulated in peripheral blood mononuclear cells in multiple sclerosis and correlate with T cell mediators91
Nicotine is an Immunosuppressant: Implications for Women's Health and Disease89
Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases60
Lymphomas mimicking neuroinflammatory diseases – A diagnostic conundrum worth revisiting57
Serum from Myalgic encephalomyelitis/chronic fatigue syndrome patients causes loss of coherence in cellular circadian rhythms50
Ursolic acid enhances social behavior and modulates Th1, Th17, and T regulatory cell-related transcription factor signaling in the BTBR T+ Itpr3tf/J mouse model of autism46
Mononuclear phagocytes in blood and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis: Untreated and treated with anti-CD20 therapy38
Cytokine profile and brain biopsy in a case of childhood-onset central nervous system vasculitis in Noonan syndrome-like disorder due to a novel CBL variant34
Effect of pharmacological intervention and pathogenesis discussion about rats with tic disorders29
A complex and severe encephalitis associated with four co-existing neuronal cell-surface autoantibodies29
The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation27
Priming of microglia by type II interferon is lasting and resistant to modulation by interleukin-10 in situ27
Genome-wide identification of murine interferon genes in microglial-mediated neuroinflammation in Alzheimer's disease24
An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote23
Microglial-mediated immune mechanisms in autoimmune uveitis: Elucidating pathogenic pathways and targeted therapeutics23
Stiff person syndrome spectrum disorders; more than meets the eye23
Characterizing double seronegative neuromyelitis optica spectrum disorder: A distinct subgroup or part of the continuum?22
Letter to the Editor Regarding “Spinocerebellar ataxia masquerading as multiple sclerosis, a case report”22
Occult cartilaginous choristoma in a child with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis22
Neuroinflammation and schizophrenia: The role of Toxoplasma gondii infection and astrocytic dysfunction22
Low vitamin D status is associated with inflammatory response in older patients with cerebral small vessel disease21
A rare cause of visual impairment in patients with multiple sclerosis: Uveitis21
Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial20
Associations between serum levels of alpha-calcitonin gene-related peptide and clinical features of neuromyelitis optica spectrum disorders20
Sjogren's syndrome meets Meige's syndrome20
Sexual dimorphism of hypothalamic serotonin release during systemic inflammation: Role of endothelin-119
Microscopic Polyangiitis With a Twist: A Rare Case of CRAO and Brainstem Infarction19
Clinical characteristics of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy in children: A case series of 16 patients19
Editorial Board19
Prognostic significance of PD-L1 and CD45RO+ cells in glioblastoma: The modulating role of MMR status18
Unilateral cortical autoimmune encephalitis: A case series and comparison to late-onset Rasmussen's encephalitis18
Immature ovarian teratomas in anti-NMDA receptor encephalitis18
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 418
Neuromyelitis optica spectrum disorder mimicking stroke: A case report and literature review18
Treatment with sofosbuvir attenuates the adverse neurodevelopmental consequences of Zika virus infection in infant rhesus macaques17
Free light chains as a reliable biomarker of intrathecal synthesis in the diagnosis of CNS inflammatory diseases17
Regulatory T cells in children with attention deficit hyperactivity disorder: A case-control study17
Heightened effector immune cell infiltration of the hippocampus concurrently with brain ventricular volume expansion in aged APP/PS1 mice16
Editorial Board16
HLA-G*14 bp indel variant in autism spectrum disorder in a population from southern Brazil16
HMGB1/TLR4 axis promotes pyroptosis after ICH by activating the NLRP3 inflammasome16
Editorial Board15
Atypical clinical and novel radiological findings in Susac syndrome: Experience from a large monocentric cohort15
Retinal pathology in spontaneous opticospinal experimental autoimmune encephalitis mice15
In memoriam: Jennifer L. Stark, PhD15
Association of interleukins 17A and 22 levels and their common genetic polymorphisms in Guillain Barré syndrome14
A 7-year-old with new-onset seizures, behavior disturbance, and encephalitis14
Anti-N-methyl-d-aspartate receptor encephalitis preceded by meningitis lasting up to 60 days14
Using interleukin-18, Eotaxin-1, and Eotaxin-3 to identify brain injury in neonates with congenital heart disease14
Ido1 or Ido2 deficiency in myeloid-derived cells attenuates TMEV-induced ictogenesis14
Exosome-transmitted ANGPTL1 suppresses angiogenesis in glioblastoma by inhibiting the VEGFA/VEGFR2/Akt/eNOS pathway13
d-serine prevents cognitive impairment in a mouse model of NMDAR encephalitis13
"Lipopolysaccharide-induced animal models for neuroinflammation – An overview."13
Clinico-pathological correlation in unilateral cortical encephalitis treated with tocilizumab after first-line treatment failure13
Characteristics and prognosis of PCA-1 (anti-Yo) autoimmunity and the utility of the Brief Ataxia Rating Scale in a seropositive cerebellar ataxia cohort13
Characterization of Japanese multiple sclerosis patients with progression independent of relapse activity: A 2-year multicenter cohort study13
Neuro-ophthalmological manifestations of sarcoidosis13
Adult-onset neurodegeneration in XMEN disease13
Distinguishing CNS neurosarcoidosis from multiple sclerosis and an approach to “overlap” cases13
Elevated serum levels of IL-10 family and IL-12 family cytokines in myasthenia gravis12
Painless progressive mononeuritis multiplex secondary to AML associated neuroleukemiosis12
Identification of the core genes KLRB1 and RETN as potential shared diagnostic markers for major depressive disorder and systemic lupus erythematosus through bioinformatics and machine learning method12
Effects of androgen modifying therapies on disease activity in older men with multiple sclerosis12
Circulating levels of inflammatory biomarkers in Huntington's disease: A systematic review and meta-analysis12
Therapeutic potential of Baicalin against experimental obsessive compulsive disorder: Evidence from CSF, blood plasma, and brain analysis12
A functional role for alpha-synuclein in neuroimmune responses12
Ginkgo biloba extract (EGb-761) confers neuroprotection against ischemic stroke by augmenting autophagic/lysosomal signaling pathway12
Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis12
Causal relationships between monocyte chemoattractant protein-1 levels and neuropsychiatric disorders: Evidence from large-scale genetic data12
Immune profiling unveils the systemic cytokine milieu associated with acute reversible encephalopathy with cytotoxic lesions of the corpus callosum (CLOCCs)12
Early life stress aggravates disease pathogenesis in mice with experimental autoimmune encephalomyelitis: Support for a two-hit hypothesis of multiple sclerosis etiology12
Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations12
Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis12
Neoehrlichiosis in patients with multiple sclerosis in Halmstad, Sweden: A case series12
Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis12
Effect on disease activity of ofatumumab in the treatment of glial fibrillary acidic protein astrocytopathy and 18F-DPA714 PET/MRI imaging assessment12
The pathophysiology of major depressive disorder through the lens of systems biology: Network analysis of the psycho-immune-neuroendocrine physiome12
Autoimmune encephalitis misdiagnosis and mimics12
Genetic deletion of c-Jun amino-terminal kinase 3 (JNK3) modestly increases disease severity in a mouse model of multiple sclerosis11
The role of the immune system in Parkinson's disease pathogenesis: A focus on Th17 cells - A systematic review and meta-analysis11
Age and sex-dependent gut alterations in mice induced by neonatal immune activation with lipopolysaccharide11
Editorial Board11
Effects of a high saturated fatty acid diet on the intestinal microbiota modification and associated impacts on Parkinson's disease development11
Glial changes in the dentate gyrus of neuronal-specific PTEN knockout mice correlate with changes in cell proliferation11
The role of TREM1 in regulating microglial polarization in sevoflurane-induced perioperative neurocognitive disorders11
Minocycline inhibits microglial activation in the CA1 hippocampal region and prevents long-term cognitive sequel after experimental cerebral malaria11
Chronic g-CSF increases the neutrophil-lymphocyte ratio and decreases plasma corticosterone concentrations in Peromyscus maniculatus without impacting compulsive-like stereotypy11
Impact of blood-brain barrier disruption on clinical features and treatment response in patients with newly diagnosed autoimmune encephalitis10
Activated microglia by 18F-DPA714 PET in a case of anti-LGI1 autoimmune encephalitis10
Iatrogenic NORSE: Immune checkpoint inhibitor-related anti-GFAP autoimmune astrocytopathy10
Macrophage-derived exosomes exacerbate postoperative cognitive dysfunction in mice through inflammation10
Are corneal nerve and dendritic cell parameters assessed via corneal confocal microscopy good markers for multiple sclerosis? – A systematic review and meta-analysis10
Editorial Board10
Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosis10
SPI1 affects Aβ1–42-induced microglia-mediated neuroinflammation by transcriptionally regulating FOSL2 expression10
Peripheral and central inflammation in depression: How large is the gap and can we bridge it with PET neuroimaging and neural-derived extracellular vesicles?10
Immunological heterogeneity in Ménière's disease: CD4+ T cell subset profiling reveals three distinct Immunophenotypes10
Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility study10
3D imaging and pathological analysis of microglia in LPS-treated mice with light-sheet fluorescence microscopy10
Peripheral neuropathy in sarcoidosis9
Cerebral amyloid angiopathy-related inflammation superimposed on alpha-synucleinopathies: a case report and literature review9
Bridging the triad: A comprehensive review of Susac's syndrome9
The medulla oblongata shows a sex-specific inflammatory response to systemic neonatal lipopolysaccharide9
Editorial Board9
Adenylate kinase 5 (AK5) autoimmune encephalitis: Clinical presentations and outcomes in three new patients9
Cadmium exposure exacerbates immunological abnormalities in a BTBR T+ Itpr3tf/J autistic mouse model by upregulating inflammatory mediators in CD45R-expressing cells9
The therapeutic effect of ofatumumab in autoimmune encephalitis: A case series9
Neuromodulator hydrogen sulfide attenuates sickness behavior induced by lipopolysaccharide9
Bioinformatics exploration of SPHKAP's role in IDH-mutant glioma involving energy metabolism, prognosis, and immune modulation9
Anti-Lactosylceramide antibody positive combined central peripheral demyelination emerging from long-standing juvenile-onset chronic inflammatory polyradiculoneuropathy; a report of two cases9
Editorial Board9
Maresin1 improves postoperative delirium-like behavior in mice with tibial fractures by inhibiting the TLR4/MyD88/NF-kB pathway9
TMEM132A autoimmunity in patients with suspected autoimmune cerebellar ataxia9
Analysis of risk factors for a poor functional prognosis and relapse in patients with autoimmune encephalitis9
Discordance of reported multiple sclerosis clinical course amongst patients and providers9
Calcitriol modulate post-ischemic TLR signaling pathway in ischemic stroke patients9
Novel biomarkers and interferon signature in secondary progressive multiple sclerosis9
Plasma TNF-α and phosphorylated α-syn are associated with fatigue in patients with Parkinson's disease9
Syringic acid suppresses inflammation by upregulation of SOCS39
Geraniol (GER) attenuated chronic sleep restriction (CSR)-induced neuroinflammation in adolescent mice9
An enjoyable career in science9
Neuro-Sjögren: A clinical-radiological paradox affecting the central nervous system9
Safety and efficacy of intrathecal rituximab in refractory neuroimmune disorders- a case series9
Apathy in autoimmune GFAP Astrocytopathy: A case series and literature review9
Human dendritic cell subsets in the glioblastoma-associated microenvironment9
Presumptive isolated neurosarcoidosis involving eloquent structures: An argument for empirical TNF-α inhibition8
Inherited chromosomally-integrated human herpes virus 6 confounding test results in a patient with myelitis and optic neuritis – A case report8
Structural and functional biomarkers of visual dysfunction in MOG antibody-positive optic neuritis: a scoping review8
The real-world experience of biologics for neuromyelitis optica spectrum disorders as first-line and switched therapy8
Fibrinolysis associated proteins and lipopolysaccharide bioactivity in plasma and cerebrospinal fluid in multiple sclerosis8
Granagard administration prolongs the survival of human mesenchymal stem cells transplanted into a mouse model of multiple sclerosis8
Ovariectomy increases paclitaxel-induced mechanical hypersensitivity and reduces anti-inflammatory CD4+ T cells in the dorsal root ganglion of female mice8
Comparison of prednisolone monotherapy vs. tacrolimus combination in NMOSD: Efficacy, safety, and optimal therapeutic timing8
When gut and nerves collide: A case of Neuromyelitis Optica Spectrum disorder after golimumab for ulcerative colitis8
Editorial Board8
Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis8
Diversity of childhood-onset myasthenia gravis: pathophysiology and treatment8
Myeloid cell heterogeneity in the tumor microenvironment and therapeutic implications for childhood central nervous system (CNS) tumors8
B cell tolerance checkpoint function in multiple sclerosis and transient CD52 depletion8
Normocomplementemic urticarial vasculitis in a patient with multiple sclerosis on glatiramer acetate8
Bergapten inhibiting NLRP3 inflammasome activation and pyroptosis to alleviate neuropathic pain in a rat mode of chronic constriction injury8
Neuronal inflammation-associated biomarkers in cerebrospinal fluid of patients with acute and chronic inflammatory demyelinating polyneuropathies8
Predictors from systemic and neuro-inflammation in amyotrophic lateral sclerosis: A monocentric experience8
Exploring the role of the IL-12/IFN-γ immune axis in subacute sclerosing panencephalitis8
Kidney injury: An overlooked manifestation in autoimmune encephalitis8
Exploring the causal role of immune cells in vascular dementia: A bidirectional mendelian randomization study8
Viral co-infection, autoimmunity, and CSF HIV antibody profiles in HIV central nervous system escape8
Free light chains analysis in cerebrospinal fluid for the diagnosis of multiple sclerosis: A study in the Israeli population8
Brain tumor detection using HyGSNet and feature extraction with DWT-based GDP8
Wash-out duration and lymphocyte count in switching from fingolimod to ofatumumab: A case report and literature review8
Elevated serum levels of C-terminal agrin fragment in acetylcholine receptor antibody-positive myasthenia gravis8
Local immunotherapy of glioblastoma: A comprehensive review of the concept8
Disordered gut microbiota and changes in short-chain fatty acids and inflammatory processes in stress-vulnerable mice8
Aggressive MOGAD with bilateral corticospinal tract lesions following infection with Jamestown Canyon virus7
Characterization of cerebral small vessel disease by neutrophil and platelet activation markers using artificial intelligence7
Editorial Board7
Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS)7
Editorial Update7
Caveolin-1 mediates blood-brain barrier permeability, neuroinflammation, and cognitive impairment in SARS-CoV-2 infection7
The PTEN-associated immune prognostic signature reveals the landscape of the tumor microenvironment in glioblastoma7
Self-delivering mRNA inhibitors of MK2 improve outcomes after spinal cord injury7
A three-compartment apparatus alters the brain concentration of cytokines and neurotrophic factors in cocaine-induced CPP in mice7
Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?7
Antibiotic treatment during pregnancy and lactation in dams exacerbates clinical symptoms and inflammatory responses in offspring with experimental autoimmune encephalomyelitis7
Fluorescence-detection size-exclusion chromatography specifically detects autoantibodies targeting the ganglionic acetylcholine receptor in patients with autoimmune autonomic ganglionopathy7
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Practical recommendations for diagnosis and management7
miR-92a-3p regulates neuropathic pain and neuroinflammation by regulating the expression of WNT5A7
Prolonged STAT1 activation in neurons drives a pathological transcriptional response7
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center7
Effect of the sEH inhibitor AUDA on arachidonic acid metabolism and NF-κB signaling of rats with postpartum depression-like behavior7
Brain tumor classification using hybrid spinal-EfficientNet using MRI images7
3D in vitro modelling of human patient microglia: A focus on clinical translation and drug development in neurodegenerative diseases7
Autoantigen and IL-2 activated CD4+CD25+T regulatory cells are induced to express CD8 and are autoantigen specific in inhibiting experimental autoimmune encephalomyelitis7
Interleukin-17 is involved in neuropathic pain and spinal synapse plasticity on mice7
Gut dysbiosis influences the pathophysiology of multiple sclerosis: A case-control study from North India7
Comparison of SIMOA and VEUS technologies for serum glial fibrillary acidic protein measurement7
Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis7
MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis7
Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan6
Characterizing the relationship between FLAIR hyper-rim lesions and paramagnetic rim lesions in multiple sclerosis6
Association of thyroid autoimmune status with Alzheimer’s disease biomarkers in euthyroid subjects6
Hypertrophic pachymeningitis with co-occurrence of anti-neutrophil cytoplasmic antibodies and immunoglobulin G4 seropositivity: Case report and literature review6
Guhong injection attenuates brain injury and promotes neuroprotection after acute ischemic stroke6
Platelets bridging the gap between gut dysbiosis and neuroinflammation in stress-linked disorders: A narrative review6
Immunostimulatory and immunomodulatory effects of duloxetine and venlafaxine on p38 MAPK and PI3K pathways6
The effect of immunosuppression or thymectomy on the response to tetanus revaccination in myasthenia gravis6
IT-DEX and B cell depletion in a child with anti-GAD 65 autoimmune encephalitis presenting as NORSE: A case report6
Weight-drop model as a valuable tool to study potential neurobiological processes underlying behavioral and cognitive changes secondary to mild traumatic brain injury6
The dilemma of demyelination: A case of Schilder's disease with insights from literature6
Efficacy and tolerability of metformin as an adjuvant therapy in patients with relapse-remitting multiple sclerosis receiving interferon Beta 1a: A randomized pilot trial6
Corrigendum to “MP4- and MOG:35–55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum” [J Neuroimmunol 189(1–2) (2007) 31–40]6
Exogenous IL-33 mitigates inflammatory responses by suppressing the NF-Κb signaling pathway, promoting blood-spinal cord barrier repair and neural functional recovery6
Possible risk of rheumatoid arthritis treated with methotrexate to the central nervous system relapse of diffuse large B-cell lymphoma6
The case report of AQP4 and MOG IgG double positive NMOSD treated with subcutaneous Ofatumumab6
Cerebellar ataxia and depression associated with anti-RhoGTPase-activating protein 26 antibody: A case report6
Double hit – A case in point for dual seropositivity to AQP4 and MOG antibodies6
Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection5
Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab5
Tumefactive demyelination as the first presentation of MOG ab-associated disease5
Management of neurosarcoidosis5
Alemtuzumab treatment exemplifies discordant immune effects of blood and cerebrospinal fluid in multiple sclerosis5
Longitudinally-extensive transverse myelitis in the setting of recent Mycoplasma infection: Case series5
Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab5
Comment on “SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fiber neuropathy by J. Finsterer5
Microglia mediated neuroinflammation in neurodegenerative diseases: A review on the cell signaling pathways involved in microglial activation5
Editorial Board5
Peripheral oedema as an adverse effect of treatment of secondary progressive multiple sclerosis with siponimod: A case series5
LRP4 antibody testing in myasthenia gravis5
Alterations in brainstem respiratory centers following peripheral inflammation: A systematic review5
The microglial endocannabinoid system is similarly regulated by lipopolysaccharide and interferon gamma5
Exploratory analysis of B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL) across migraine phases5
RIPK3-MLKL dependent necroptosis mediates depressive-like behavior by facilitating neuroinflammation5
Atractylodin ameliorates lipopolysaccharide-induced depressive-like behaviors in mice through reducing neuroinflammation and neuronal damage5
Bladder dysfunction in experimental autoimmune encephalomyelitis reflects clinical severity: A pilot study5
Three-year follow-up of rheumatoid meningitis with matrix metalloprotease-9 levels in the serum and cerebrospinal fluid as indicators of disease activity: A case report5
Clinical outcome and peripheral CD4+ T profile in impending myasthenic crisis: A prospective cohort study5
Editorial Board5
Immune dysfunction in the cerebellum of mice lacking the autism candidate gene Engrailed 25
Immunotherapy challenges and potential role of unclassified antibodies in complex autoimmune encephalitis5
Anti-contactin-associated protein 1 antibody-positive nodopathy presenting with central nervous system symptoms5
Neurotropic murine coronavirus mediated demyelination: Factors dampening pathogenesis5
miR-485 regulates Th17 generation and pathogenesis in experimental autoimmune encephalomyelitis through targeting STAT35
ITPR1 autoantibody-associated autoimmunity as a cause of newly emerging cognitive decline mimicking Alzheimer's disease: Case report and brief review of the literature5
Susac syndrome with the typical clinical triad: A case report and literature review5
Corrigendum to “Germinal center B cells are dispensable in prion transport and neuroinvasion”. [2007 Dec;192(1–2):113–23. doi: 10.1016/j.jneuroim.2007.09.022. Epub 2007 Oct 26. PMID: 17964667]5
A Neuroimmunological Axis between systemic autoimmunity and Parkinson's disease following long-COVID: A case series5
Corrigendum to “Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis” [Journal of neuroimmunology vol. 5
Editorial Board5
Offspring behavioral outcomes following maternal allergic asthma in the IL-4-deficient mouse5
The status of knowledge on migraines: The role of microglia5
Epileptic seizures in patients with anti-IgLON5 disease5
Targeting extracellular matrix components to attenuate microglia neuroinflammation: A study of fibulin-2 and CSPGs in a model of multiple sclerosis5
Anti-Tr/DNER antibody-associated rapidly progressive cerebellar degeneration in anaplastic large cell lymphoma: A case report with literature review5
Cholesterol dysregulation in peripheral blood mononuclear cells of Alzheimer's disease4
Calycosin regulates astrocyte reactivity and astrogliosis after spinal cord injury by targeting STAT3 phosphorylation4
The role of the QT interval in predicting functional prognosis in patients with acute ischemic stroke4
May high mobility group box protein-1 be a biomarker for major depressive disorder?4
Docosahexaenoic acid supplementation aggravates myasthenia gravis through immune dysregulation4
Immune dysregulation in chronic inflammatory demyelinating polyneuropathy4
Genetically reduced MTHFR activity confers protection against multiple sclerosis4
Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis4
As time goes by: Treatment challenges in elderly people with multiple sclerosis4
Fingolimod attenuates gait deficits in mice subjected to experimental autoimmune encephalomyelitis4
Prolonged corticosteroid therapy and steroid-sparing maintenance immunotherapy lower relapse risk in pediatric and adult MOGAD4
Endocrine disrupting chemicals in early MS disease activity4
Inflammatory profile and white matter hyperintensity burden in acute ischemic stroke patients4
Prolonged and intense neuroinflammation after severe traumatic brain injury assessed by cerebral microdialysis with 300 kDa membranes4
Electroconvulsive therapy for catatonia in anti-NMDA receptor encephalitis: A case series4
Anti-LGI1 encephalitis: A family affair4
0.054497003555298